Events

The State of Care: Patient Access & Affordability

The Atlantic will gather key perspectives to continue the conversation on what it costs to stay healthy in America today.

Examining the Pharmaceutical Supply Chain: From Production to Patient

On November 14, 2017, RealClearPolitics—in partnership with The Value Collaborative—brought together a cross-section of experts to examine the biopharmaceutical supply chain.

Vaccines + Immunity: Examining Modern Medicine

How can scientists and researchers effectively engage with the public? Are vaccines a matter of personal choice or public health? What will the future of vaccines look like? The Atlantic gathered stakeholders from public health officials to the medical and scientific community to explore these questions at a forum in Philadelphia.

Future Shapers: A New Era in Cancer Innovation

A series of discussions on the innovations and solutions needed to accelerate efforts towards ending cancer as we know it including conversation with The Honorable Joseph R. Biden Jr.

Research & Hope Awards 2017

These Awards illustrate how biopharmaceutical researchers and others in the innovation ecosystem work together to bring new medical advances to patients.

The Future of Health Care: Unlocking & Supporting Value

The Value Collaborative partnered with Bloomberg to convene CEOs, experts and thought leaders to discuss how stakeholders are working together to unlock and support value in the future of health care.

Precision Medicine Leaders Summit Spotlight: Paying for Personalized Value

The Value Collaborative sponsored a panel of distinguished leaders from the diagnostic, academic and patient communities.

Innovation Pipeline: Examining Modern Medicine

In the third event of the “Examining Modern Medicine” series, The Atlantic will gather stakeholders, original thinkers and trailblazers from the nation’s innovation capital to explore what it means to put the bio into biotech.

Turning the Tide Against Cancer National Conference Spotlight: Partnering to Deliver High-Value Care for Patients

The Turning the Tide Against Cancer National Conference convened leaders from across the oncology community to explore the role of the patient across the continuum of cancer research and care and identify strategies that policymakers might consider to support meaningful patient engagement and deliver value to patients.

The Brain: The Next Frontier

In order to jumpstart a dialogue on the many complex issues impacting the brain, PhRMA is bringing together industry thought leaders, researchers and scientists in Los Angeles for a conversation titled “The Brain: The Next Frontier.”

Prioritizing Patients: A Discussion on Outcomes-Based Care

Sequencing the Genome: Examining Modern Medicine

At a forum in New York, The Atlantic will gather key stakeholders to discuss the future of the genomic era.

Future Shapers: New Cures, New Innovators for a New Era in Mental Health

PhRMA and Axios hosted a discussion on innovation in mental health care with perspectives from experts in technology, biopharmaceutical innovation, community and public advocacy.

A New Negotiation: Moving Payment for Medicines from Volume to Value

Across the health care system there is a movement to better pay for services based on outcomes. Join America's biopharmaceutical companies for a discussion on ways the private prescription medicine marketplace can evolve to produce and reward better value for patients.

Through the Microscope: Examining Modern Medicine

The Pharmaceutical Research and Manufacturers of America (PhRMA) will hold its first national health care dialogue series on February 21, 2017 in Boston, Massachusetts, as part of its new GOBOLDLY campaign and The New Era of Medicine initiative.

Tackling Diabetes: Solutions to a Complex Disease

On December 6th, 2016, PhRMA gathered members of Congress, leaders in the diabetes community, payers, providers and the biopharmaceutical industry in coordination with The Hill publication at The Newseum for a special event titled, “Tackling Diabetes: Solutions to a Complex Disease.”

2016 Congressional Fly-In

PhRMA is bringing 60+ researchers to meet with members of Congress to discuss how they can support development of innovative treatments.

PhRMA Annual Meeting 2016

The Annual Meeting brings together business leaders, policymakers and industry experts to take an in depth look at the state of science and health.